Fulcrum Therapeutics, Inc. Annual Return On Assets in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Fulcrum Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from 2020 to 2023.
  • Fulcrum Therapeutics, Inc. Return On Assets for the quarter ending June 30, 2024 was -7.61 %, a 78.8% increase year-over-year.
  • Fulcrum Therapeutics, Inc. annual Return On Assets for 2023 was -33.6 %, a 31.9% increase from 2022.
  • Fulcrum Therapeutics, Inc. annual Return On Assets for 2022 was -49.4 %, a 19.9% decline from 2021.
  • Fulcrum Therapeutics, Inc. annual Return On Assets for 2021 was -41.2 %, a 25.6% increase from 2020.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -33.6 +15.8 +31.9% Jan 1, 2023 Dec 31, 2023
2022 -49.4 -8.18 -19.9% Jan 1, 2022 Dec 31, 2022
2021 -41.2 +14.2 +25.6% Jan 1, 2021 Dec 31, 2021
2020 -55.4 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.